ONCOLYTICS BIOTECH INC. Liabilities
ONCOLYTICS BIOTECH INC. (ONCY) had Liabilities of CAD 14.20 million as of 2024-12-31, per its 20-F filed 2025-03-07.
Financial Statements › Notes
ifrs-full:Liabilities · last filed 2025-03-07
- 2024-12-31: Liabilities 14.20M CAD.
- 2023-12-31: Liabilities 11.26M CAD.
- 2022-12-31: Liabilities 10.83M CAD.
- 2021-12-31: Liabilities 9.78M CAD; Liabilities as first filed 9.78M CAD.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2024-12-31 | 14.20M CAD 20-F · filed 2025-03-07 | |
| 2023-12-31 | 11.26M CAD 20-F · filed 2025-03-07 | |
| 2022-12-31 | 10.83M CAD 20-F · filed 2024-03-12 | |
| 2021-12-31 | 9.78M CAD 20-F · filed 2023-03-03 | 9.78M CAD 20-F · filed 2022-03-03 |
| 2020-12-31 | 9.59M CAD 20-F · filed 2022-03-03 | |
| 2019-12-31 | 19.77M CAD 20-F · filed 2021-03-05 | |
| 2019-01-01 | 9.48M CAD 20-F · filed 2020-03-06 | |
| 2018-12-31 | 8.67M CAD 20-F · filed 2020-03-06 | |
| 2017-12-31 | 9.87M CAD 20-F · filed 2019-03-15 | |
| 2016-12-31 | 4.07M CAD 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |